Texas House of Representatives · 89th Legislature, Regular Session
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)89R
AI summary unavailable. We’re still building out our data, so newer and more active legislation has better coverage.
Each version links to the authoritative document on capitol.texas.gov.
89R1261 JG-F By: Harrison H.B. No. 855 A BILL TO BE ENTITLED AN ACT relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subtitle A, Title 6, Health and Safety Code, is amended by adding Chapter 446 to read as follows: CHAPTER 446. OFF-LABEL USE OF PRESCRIPTION DRUGS
Sec. 446.001. DEFINITIONS. In this chapter: (1) "Off-label use" means the use of a prescription drug approved for use by the United States Food and Drug Administration in a manner other than the approved use. (2) "Pharmacist" means a person licensed by the Texas State Board of Pharmacy to practice pharmacy. (3) "Physician" means an individual licensed by the Texas Medical Board to practice medicine in this state. Sec. 446.002. APPLICABILITY. This chapter applies only to the promoting, prescribing, administering, and dispensing of a prescription drug the United States Food and Drug Administration has approved for human use. Sec. 446.003. PROHIBITED DISCIPLINARY ACTION AGAINST PHYSICIAN'S OR PHARMACIST'S LICENSE. (a) Except as provided by Subsection (b), the state agency with licensing or regulatory authority over a physician or pharmacist may not revoke, fail to renew, suspend, or take any other adverse action against a physician's or pharmacist's license based solely on the physician or pharmacist: (1) prescribing, administering, or dispensing a prescription drug for off-label use to treat a patient; or (2) communicating or otherwise promoting to a patient an off-label use of a prescription drug. (b) The state agency with licensing or regulatory authority over a physician or pharmacist may revoke, fail to renew, suspend, or take any other adverse action against a physician's or pharmacist's license based on conduct described by Subsection (a)(1) or (2) if, after notice and hearing, the agency proves beyond a reasonable doubt that: (1) the conduct caused the physician's or pharmacist's patient to suffer physical harm; and (2) the initial onset of the patient's physical harm occurred not later than three years after the date of the physician's or pharmacist's conduct. SECTION 2. The changes in law made by this Act apply only to a prescription issued or a prescription drug promoted, administered, or dispensed on or after the effective date of this Act. SECTION 3. This Act takes effect September 1, 2025.
SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 89R bills tagged the same way.
SourceTexas Legislative Council (capitol.texas.gov)89R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)89R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
SourceLegiScan (CC BY 4.0)subject tags